ARCHIVES

FDA Approves Bayer’s Xofigo For Late-Stage Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

October 31, 2014

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

In Brief: MSKCC Launches Molecular Oncology, Genomic Center

May 23, 2014

NIH Programs: Varmus Appoints 20 To Council of Public Representatives

April 30, 1999

NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face

January 16, 1987

Lasker Awards Announced

September 25, 2009